Selamectin (Revolution)

Selamectin is a semi-synthetic avermectin antiparasitic agent that belongs to the macrocyclic lactone class of medications. This topical medication works by interfering with chloride channel conductance in nerve and muscle cells of parasites, leading to paralysis and death of the target organisms. Selamectin is particularly effective against a broad spectrum of external and some internal parasites, making it an invaluable tool in exotic veterinary medicine for treating small mammals affected by various parasitic infestations.

Developed initially for use in dogs and cats, selamectin has become widely adopted for extra-label use in small mammals due to its excellent safety profile and ease of administration. The medication was first approved by the FDA in 1999 under the brand name Revolution, and has since become one of the most trusted antiparasitic agents for companion animals. Its application in exotic pet medicine has grown substantially as veterinarians recognized its effectiveness and safety in species such as ferrets, rabbits, guinea pigs, and other small mammals when used at appropriate doses.

Selamectin is available exclusively as a topical solution designed for spot-on application between the shoulder blades or on the back of the neck. The medication comes in single-dose tubes of varying concentrations, allowing veterinarians to select the appropriate strength based on the species and body weight of the patient. For small mammals, the smallest concentration tubes designed for kittens or puppies are most commonly used, though compounding may be necessary for very small patients such as hamsters or mice. The lipophilic nature of selamectin allows it to be absorbed through the skin and distributed throughout the body via the sebaceous glands and bloodstream.

The overall safety profile of selamectin in small mammals is considered excellent when used at appropriate doses under veterinary supervision. Unlike some other antiparasitic agents, selamectin does not typically cause the severe neurological side effects associated with ivermectin toxicity in sensitive individuals. However, as with any medication used extra-label in exotic species, careful consideration of species-specific factors and precise dosing is essential. The medication provides protection against parasites for approximately one month following application, making it convenient for both treatment and prevention protocols.

Selamectin serves as a first-line treatment for numerous ectoparasite infestations in small mammals. The medication is highly effective against fur mites including Cheyletiella species, Myocoptes musculinus, Myobia musculi, and Radfordia species that commonly affect rodents and rabbits. These mites cause significant discomfort, hair loss, and skin irritation in affected animals, and selamectin provides reliable elimination of these parasites with its systemic distribution through the skin and sebaceous secretions.

Ear mite infestations caused by Psoroptes cuniculi in rabbits and Otodectes cynotis in ferrets respond exceptionally well to selamectin treatment. The medication reaches therapeutic concentrations in the ear canal through systemic distribution, eliminating the need for direct ear application that can be stressful for both patient and owner. This systemic approach ensures that mites throughout the ear canal are exposed to the medication, often providing more complete treatment than topical ear preparations alone.

In ferrets specifically, selamectin is commonly prescribed for flea prevention and treatment. The medication is considered safe for ferrets and provides month-long protection against flea infestations. This is particularly important because ferrets are sensitive to permethrin-containing products that are commonly used in dogs, making selamectin a preferred alternative for flea control in this species. Additionally, selamectin provides protection against heartworm disease in ferrets living in endemic areas.

Sarcoptic mange caused by Sarcoptes scabiei can affect various small mammal species and responds well to selamectin therapy. The burrowing nature of these mites makes topical treatments challenging, but selamectin's systemic distribution ensures the medication reaches mites within the skin layers. Treatment typically requires multiple applications at monthly intervals to fully eliminate the infestation and break the reproductive cycle of the mites.

Beyond ectoparasites, selamectin demonstrates activity against certain internal parasites. The medication is effective against some intestinal roundworms and can help control hookworm infections in small mammals. While not typically considered a primary dewormer for exotic species, this additional antiparasitic activity can be beneficial in animals with concurrent internal and external parasite burdens. Veterinarians may choose selamectin when treating animals with multiple parasite types to simplify the treatment protocol.

The administration of selamectin in small mammals requires careful attention to species-specific factors and precise application technique. As this medication is used extra-label in exotic species, all dosing decisions must be made by a qualified exotic animal veterinarian who can assess the individual patient and determine the appropriate dose based on current veterinary literature and clinical experience. Owners should never attempt to dose small mammals without specific veterinary guidance, as improper dosing can lead to treatment failure or adverse effects.

Selamectin is applied topically to the skin between the shoulder blades or on the back of the neck where the animal cannot easily groom it away. For larger small mammals such as rabbits and ferrets, application is straightforward using the manufacturer's pipette tips. The fur should be parted to expose the skin, and the entire contents of the appropriate-sized tube should be applied directly to the skin surface. The medication should be allowed to dry completely before the animal is returned to its enclosure or allowed contact with cage mates.

For very small patients including hamsters, gerbils, mice, and small rats, the commercially available formulations may need to be diluted or compounded to achieve accurate dosing. Many exotic veterinarians work with compounding pharmacies to prepare selamectin at concentrations appropriate for these tiny patients. This ensures accurate dosing while maintaining the medication's stability and efficacy. Owners should only use compounded preparations obtained through their veterinarian from reputable compounding pharmacies.

The frequency of administration depends on the condition being treated and the parasite's life cycle. For active mite infestations, treatment is typically repeated at two to four week intervals for two to three treatments to ensure elimination of both adult mites and newly hatched juveniles that were present as eggs during the initial treatment. For flea prevention in ferrets, monthly application is standard practice. Your exotic veterinarian will establish the appropriate treatment schedule based on the specific diagnosis and the individual patient's needs.

Special considerations apply when treating animals housed in groups. Because parasites can spread between cage mates, all animals in contact with an infested individual should typically be treated simultaneously. Additionally, environmental decontamination is often necessary to prevent reinfestation, particularly with mites that have environmental stages. Your veterinarian can provide guidance on appropriate environmental treatment measures to complement the selamectin therapy.

Post-application monitoring is important to assess treatment response. Owners should observe for resolution of clinical signs such as scratching, hair loss, and skin lesions over the weeks following treatment. If signs persist or recur, follow-up veterinary examination is warranted to determine whether additional treatment is needed or whether an alternative diagnosis should be considered. Documentation of the application date helps ensure appropriate timing of subsequent doses when repeated treatment is prescribed.

Selamectin is generally well-tolerated in small mammals when used at appropriate doses, but owners should be aware of potential side effects and know when to seek veterinary attention. The most commonly observed side effect is temporary hair loss at the application site. This localized alopecia typically resolves within a few weeks without treatment and is thought to result from the vehicle solution rather than the active ingredient itself. While cosmetically concerning, this reaction is not harmful to the animal.

Mild skin reactions at the application site may occur in some individuals. These can include redness, mild irritation, or flaking skin where the medication was applied. Such reactions are usually self-limiting and resolve without intervention. If significant skin irritation develops or persists beyond a few days, veterinary evaluation is recommended to rule out an allergic reaction or other underlying skin condition that may have been unmasked by the treatment.

Gastrointestinal signs including decreased appetite, soft stool, or mild lethargy have been reported occasionally following selamectin application in small mammals. These effects are typically transient and resolve within twenty-four to forty-eight hours. However, because small mammals can deteriorate quickly when not eating, any significant or prolonged decrease in appetite warrants prompt veterinary attention. Guinea pigs and rabbits are particularly sensitive to anorexia and should be monitored closely following any medication administration.

Neurological side effects are rare with selamectin at recommended doses but can occur with overdose or in particularly sensitive individuals. Signs of toxicity may include excessive salivation, tremors, incoordination, or lethargy. These effects relate to the drug's mechanism of action on neurological chloride channels and are more likely if the dose was inappropriately high or if the animal ingested the medication by grooming before it dried. Any neurological signs following selamectin application require immediate veterinary evaluation.

Owners should contact their veterinarian immediately if they observe severe or persistent lethargy, complete refusal to eat for more than twelve to twenty-four hours depending on species, neurological signs such as tremors, seizures, or inability to walk normally, severe skin reactions including swelling or widespread irritation, or any other concerning changes in their pet's behavior or condition following treatment. While serious adverse effects are uncommon, prompt veterinary attention can be critical in managing any unexpected reactions.

Selamectin should not be used in animals with known hypersensitivity to selamectin or other avermectin compounds. Although true allergic reactions are uncommon, animals that have experienced adverse reactions to previous selamectin applications or to related medications such as ivermectin or moxidectin should not receive this medication without careful veterinary risk assessment. Alternative antiparasitic treatments are available for patients with documented sensitivity to macrocyclic lactones.

Extreme caution is warranted when considering selamectin use in very young, very old, or debilitated animals. Neonatal and juvenile small mammals may have immature metabolic systems that affect drug processing, while geriatric or systemically ill patients may have compromised organ function that alters drug elimination. In these vulnerable populations, the exotic veterinarian must carefully weigh the benefits of treatment against potential risks and may choose alternative therapies or adjusted dosing protocols.

Animals with active skin infections, open wounds, or severely damaged skin at potential application sites may not be suitable candidates for topical selamectin therapy until these conditions are addressed. Compromised skin integrity can affect drug absorption and distribution, potentially leading to unpredictable blood levels. Additionally, applying medication to infected or wounded skin may cause discomfort or interfere with wound healing. Your veterinarian may recommend treating skin conditions before initiating selamectin therapy or may select alternative routes or medications.

Pregnant and nursing animals require special consideration before selamectin administration. While studies in dogs and cats suggest reasonable safety during pregnancy, limited data exist for exotic small mammal species. The decision to treat pregnant or nursing small mammals with selamectin should involve careful discussion with your exotic veterinarian about the relative risks of untreated parasitism versus potential medication effects on developing or nursing young. In some cases, treatment may be delayed until after weaning, or alternative approaches may be recommended.

Drug interactions with selamectin in small mammals are not extensively documented, but certain combinations warrant caution based on pharmacological principles and clinical experience. Concurrent use of other medications that affect gamma-aminobutyric acid pathways or chloride channel function should be approached carefully. This includes other avermectin or milbemycin antiparasitics, certain anesthetic agents, and some anticonvulsant medications. When multiple medications affecting these systems are combined, there may be increased risk of neurological effects.

The use of selamectin alongside other topical medications requires consideration of potential interactions at the application site. Applying multiple topical products to the same skin area may affect absorption of each medication or increase the risk of skin irritation. If both selamectin and other topical treatments are needed, your veterinarian may recommend applying them to different body areas or spacing applications by several hours to days. Always inform your veterinarian of any other medications or topical products your small mammal is receiving.

Selamectin should be used cautiously in animals receiving medications that affect drug metabolism in the liver, particularly those that inhibit cytochrome P450 enzymes. While selamectin undergoes minimal hepatic metabolism compared to some other drugs, significantly impaired liver function or concurrent use of certain medications could theoretically affect drug handling. Animals with known liver disease should be carefully evaluated before selamectin administration, and alternative treatments may be preferable in some cases.

Despite these considerations, selamectin has a relatively favorable drug interaction profile compared to many other antiparasitics. It is commonly used safely in animals receiving antibiotics, pain medications, or other treatments for concurrent conditions. However, complete medication disclosure to your exotic veterinarian is essential for safe prescribing. This includes prescription medications, over-the-counter products, supplements, and any herbal or alternative treatments being given. Your veterinarian can assess potential interactions and develop a safe, comprehensive treatment plan.

Proper handling and application of selamectin requires attention to both animal and human safety considerations. The medication should be applied only to the skin of the intended patient, and handlers should avoid direct skin contact with the wet medication. While brief incidental contact is unlikely to cause harm in humans, some individuals may experience skin irritation or allergic reactions. Wearing disposable gloves during application is recommended, and hands should be washed thoroughly after handling the medication or the treated animal before the application site has dried.

Treated animals should be kept separated from cage mates and other pets until the application site is completely dry, which typically takes thirty minutes to two hours depending on the formulation and amount applied. This prevents other animals from grooming the medication from the treated animal, which could result in oral exposure and potential toxicity in the grooming animal. Children should not handle treated animals until the application has completely dried to prevent incidental exposure.

Small mammals requiring selamectin treatment should be weighed accurately before each application to ensure appropriate dosing. Given the small body size of many exotic patients, even small variations in weight can significantly affect the relative dose received. Regular weighing also helps detect weight changes that might indicate disease progression or treatment response. Most exotic veterinarians will weigh patients at each visit and calculate the specific dose needed for that individual.

Environmental considerations are important for successful parasite elimination. Many mite species can survive off the host for varying periods, and environmental contamination can lead to reinfestation of treated animals. Depending on the parasite involved, your veterinarian may recommend thorough cleaning and treatment of the enclosure, disposal or replacement of bedding and fabric items, and potentially environmental treatments to eliminate parasites and eggs. Without addressing environmental contamination, treatment of the animal alone may not resolve the infestation.

Monitoring requirements following selamectin administration include observation for any adverse effects as well as assessment of treatment efficacy. Owners should perform daily checks of their small mammal for the first few days after treatment, watching for any signs of reaction. Follow-up veterinary appointments are typically scheduled two to four weeks after treatment to assess response and determine whether additional doses are needed. Persistent or worsening symptoms despite treatment may indicate treatment failure, resistance, incorrect diagnosis, or concurrent conditions requiring different management.

Selamectin should be stored at controlled room temperature, typically between fifteen and thirty degrees Celsius or fifty-nine and eighty-six degrees Fahrenheit. The medication should be kept in its original packaging until use to protect it from light exposure, which can degrade the active ingredient over time. Storage in excessively warm conditions, such as in a car during summer months, should be avoided as elevated temperatures can affect medication stability and potency.

Unused portions of selamectin tubes should be disposed of properly rather than saved for future use. Once a single-dose tube is opened, the medication may begin to degrade or become contaminated, and accurate dosing from a partial tube is difficult. Most veterinarians recommend using the entire appropriate-sized dose at once rather than attempting to save and reuse partial tubes. For very small patients where compounding is used, follow the compounding pharmacy's specific storage and expiration guidelines, as compounded formulations may have different stability characteristics than the original product.

Safe disposal of unused or expired selamectin involves preventing environmental contamination and accidental exposure. The medication should not be disposed of by flushing down drains or toilets, as avermectin compounds can be harmful to aquatic organisms. Many communities have pharmaceutical take-back programs or hazardous waste collection events where unused veterinary medications can be safely disposed. Alternatively, mixing the medication with an unpalatable substance such as coffee grounds in a sealed container before placing it in household trash can help prevent accidental exposure or intentional misuse.

Ferrets respond particularly well to selamectin and it is considered one of the safest antiparasitic options for this species. The medication is commonly used for flea prevention and treatment, ear mite elimination, and heartworm prevention in ferrets. Unlike dogs, ferrets cannot safely use permethrin-containing flea products, making selamectin an essential alternative. The kitten-sized formulation is typically appropriate for most ferrets, though your veterinarian will determine the exact dosing based on your ferret's weight. Monthly application provides reliable protection against common parasites.

Guinea pigs and chinchillas commonly suffer from fur mite infestations that respond well to selamectin therapy. These species generally tolerate the medication well, though accurate dosing is essential given their intermediate size among small mammals. The long lifespan of chinchillas means they may require periodic antiparasitic treatments throughout their lives, and selamectin's safety profile makes it suitable for repeated use when needed. Guinea pigs receiving selamectin should be monitored for normal appetite and fecal output following treatment, as any gastrointestinal disturbance requires prompt attention in this species.

Rabbits frequently develop ear mite infestations with Psoroptes cuniculi, and selamectin provides effective systemic treatment that reaches mites throughout the ear canal. The medication is also effective against fur mites and provides some protection against intestinal parasites. Rabbit owners should monitor their pets closely following selamectin application for normal eating and fecal production, as rabbits are highly susceptible to gastrointestinal complications when stressed or feeling unwell.

Hamsters, gerbils, mice, and rats can all be affected by various mite species and may benefit from selamectin treatment. However, their small body size presents dosing challenges that typically require compounding to achieve accurate, safe doses. These species have relatively short lifespans, and treatment decisions should consider the overall health status and prognosis of the individual animal. Hedgehogs frequently develop mite infestations and generally tolerate selamectin well, making it a first-line treatment choice for this species. Sugar gliders require careful dosing due to their small size, and treatment should only be undertaken by veterinarians experienced with this species.

Ivermectin represents an alternative avermectin antiparasitic that has been used extensively in small mammals for mite treatment. While effective, ivermectin has a narrower safety margin than selamectin and carries greater risk of toxicity, particularly with repeated dosing or in sensitive individuals. Ivermectin is typically administered orally or by injection rather than topically, which may be advantageous or disadvantageous depending on the specific situation and patient. Some veterinarians prefer ivermectin for severe or resistant infestations where injectable administration ensures complete drug delivery.

Moxidectin is another macrocyclic lactone antiparasitic that is sometimes used in small mammals. Like selamectin, it is available in topical formulations, and its longer duration of action may be advantageous for some applications. However, less clinical experience exists with moxidectin in exotic small mammals compared to selamectin, and it may not be the first choice for practitioners less familiar with its use in these species. The combination product containing moxidectin and imidacloprid provides both internal and external parasite control.

For situations where avermectin-class drugs are contraindicated or ineffective, alternative antiparasitic agents may be considered. Fipronil is effective against fleas but is not safe for use in rabbits. Imidacloprid is used for flea control in some small mammals. For internal parasites, fenbendazole and other benzimidazole dewormers provide options for treating conditions not addressed by selamectin's spectrum of activity. Your exotic veterinarian can recommend the most appropriate antiparasitic medication based on the specific parasites involved, the species being treated, and any individual patient factors that affect drug selection.